Somatic mutations of calreticulin in myeloproliferative neoplasms

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Recurrent somatic mutations in the calreticulin (CALR) gene were identified in myeloproliferative neoplasms (MPNs) in 2013.
• These mutations are typically small insertions/deletions in exon 9, causing a +1 frameshift and altered carboxyl-terminus.
• CALR mutations are considered gain-of-function but lacked a clear mechanistic link to MPN pathogenesis.

Purpose of the Study:

• To review the novel molecular mechanism by which mutant calreticulin contributes to MPN pathogenesis.
• To elucidate how mutant calreticulin leads to constitutive activation of cytokine receptors.
• To explain the induction of cellular transformation in MPNs driven by CALR mutations.

Main Methods:

• Review of recent findings on CALR mutations and MPN pathogenesis.
• Analysis of the molecular chaperone function of calreticulin.
• Investigation of cytokine receptor signaling pathways.

Main Results:

• Mutant calreticulin acts as a molecular chaperone that constitutively activates cytokine receptors.
• This aberrant activation leads to cellular transformation.
• The specific frameshift mutation in CALR exon 9 is crucial for this gain-of-function activity.

Conclusions:

• Mutant calreticulin drives MPN development through constitutive cytokine receptor activation.
• Understanding this mechanism provides insights into MPN pathogenesis.
• Targeting the CALR-cytokine receptor interaction may offer therapeutic strategies for MPNs.